AnPac Bio-Medical Science Co Operating Income

AnPac Bio-Medical Science Co (ANPC) currently reports a operating income of $-100M as of December 2022. That compares with $-110M in the prior-year period — up 6.5% year over year. Use the charts on this page to explore AnPac Bio-Medical Science Co's operating income history and peer comparisons.

AnPac Bio-Medical Science Co's operating income increased from $-110M to $-100M — a 6.5% year-over-year increase (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AnPac Bio-Medical Science Co reported $-100M in operating income as of December 2022. That compares with $-110M in the prior-year period — up 6.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-100M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AnPac Bio-Medical Science Co, and consider following ANPC for alerts when major investors trade the stock.

AnPac Bio-Medical Science Co is classified in the Healthcare sector. On operating income, it currently shows $-100M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ANPC with unrelated industries.